ImmuCell Corporation: 10-Q filed 2015-11-12
What ImmuCell Corporation reported in its quarterly report filed 2015-11-12 (fiscal Q3 2015): 37 published measures, 107 facts as tagged in accession 0001213900-15-008486.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-11-12
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001213900-15-008486 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ImmuCell Corporation filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 14,223,146 | USD | |
| At 2014-12-31 | 11,051,854 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 3,924,663 | USD | |
| At 2014-12-31 | 1,793,486 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 10,298,483 | USD | |
| At 2014-12-31 | 9,258,368 | USD | |
| At 2014-09-30 | 9,123,691 | USD | |
| At 2013-12-31 | 9,395,869 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 2,469,087 | USD | |
| At 2014-12-31 | 850,028 | USD | |
| At 2014-09-30 | 1,166,211 | USD | |
| At 2013-12-31 | 2,270,385 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 351,292 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 924,432 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 10,330 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -297,786 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 2,070,116 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 50,465 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 1,772,091 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 520,142 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 2,476,819 | USD | 273 |
| 2014-01-01 to 2014-09-30 | -138,497 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | -2,927,876 | USD | 273 |
| 2014-01-01 to 2014-09-30 | -1,016,142 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 349,865 | USD | |
| At 2014-12-31 | -574,567 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 3,052,175 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 3,038,111 | shares | 273 |
| 2014-07-01 to 2014-09-30 | 3,027,034 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 3,026,990 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 3,188,349 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 3,162,620 | shares | 273 |
| 2014-07-01 to 2014-09-30 | 3,105,832 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 3,026,990 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 0.12 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | 0.3 | USD/shares | 273 |
| 2014-07-01 to 2014-09-30 | 0 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | -0.1 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 0.11 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | 0.29 | USD/shares | 273 |
| 2014-07-01 to 2014-09-30 | 0 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | -0.1 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 260,447 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 709,394 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 19,277 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -146,101 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 4,955,614 | USD | |
| At 2014-12-31 | 3,837,647 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 6,342 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 17,825 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 4,974 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 22,265 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 626,850 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 1,660,885 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 40,853 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -405,254 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 8,187,315 | USD | |
| At 2014-12-31 | 5,468,937 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 679,886 | USD | |
| At 2014-12-31 | 1,008,749 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 789,214 | USD | |
| At 2014-12-31 | 1,005,292 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 985,052 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 2,932,515 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 1,037,043 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 3,511,568 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 864,444 | USD | |
| At 2014-12-31 | 945,755 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 1,611,902 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 4,593,400 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 1,077,896 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 3,106,314 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 301,746 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 904,170 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 361,232 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 1,716,114 | USD | 273 |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | -71,390 | USD | |
| At 2014-12-31 | -23,331 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 9,563,198 | USD | |
| At 2014-12-31 | 8,283,635 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | -4,607,584 | USD | |
| At 2014-12-31 | -4,445,988 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 49,615 | USD | |
| At 2014-12-31 | 18,930 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 275,559 | USD | |
| At 2014-12-31 | 148,399 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 611,739 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 1,633,826 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 29,607 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -443,887 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 302,145 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 876,373 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 15,347 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -297,593 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 301,566 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 941,417 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 302,216 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 873,866 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 378,475 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 330,796 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 15,111 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 27,059 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 11,246 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 38,633 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | -222,207 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | -81,311 | USD | 273 |
| 2014-01-01 to 2014-09-30 | -167,062 | USD | 273 |
Inspect the source
- Entity
- ImmuCell Corporation / CIK 0000811641
- Captured
- SEC response SHA-256
e6fd54c346f29af23b63003a8b733aa2d9275cd6689854dc3a6eebcd0ca809e7
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000811641.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))